SLGL
Sol Gel Technologies Ltd
$
11.000
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
11.110
Open
10.500
VWAP
10.83
Vol
11.23K
Mkt Cap
30.64M
Low
10.485
Amount
121.60K
EV/EBITDA(TTM)
--
Total Shares
27.86M
EV
10.80M
EV/OCF(TTM)
--
P/S(TTM)
12.00
Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q1
FY2024Q4
2.90M
-46.62%
-0.700
-200%
1.20M
+157.51%
-1.200
-47.83%
2.00M
+347.43%
-1.100
-35.29%
Estimates Revision
The market is revising No Change the revenue expectations for Sol-Gel Technologies Ltd. (SLGL) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 40.63%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Up
+40.63%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for Sol Gel Technologies Ltd (SLGL.O) is -2.48, compared to its 5-year average forward P/E of -6.66. For a more detailed relative valuation and DCF analysis to assess Sol Gel Technologies Ltd 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-6.66
Current PE
-2.48
Overvalued PE
51.16
Undervalued PE
-64.48
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-7.45
Current EV/EBITDA
0.97
Overvalued EV/EBITDA
8.15
Undervalued EV/EBITDA
-23.05
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
13.49
Current PS
3.37
Overvalued PS
32.95
Undervalued PS
-5.96
Financials
Annual
Quarterly
FY2025Q1
YoY :
+121.24%
1.03M
Total Revenue
FY2025Q1
YoY :
+35.12%
-9.07M
Operating Profit
FY2025Q1
YoY :
+38.84%
-8.81M
Net Income after Tax
FY2025Q1
YoY :
+1286.84%
-31.62
EPS - Diluted
FY2025Q1
YoY :
0.00%
100.00
Gross Profit Margin - %
FY2025Q1
N/A
FCF Margin - %
FY2025Q1
YoY :
-37.25%
-854.32
Net Margin - %
FY2025Q1
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
SLGL News & Events
Events Timeline
2025-05-23 (ET)
2025-05-23
07:20:53
Sol-Gel Technologies sees cash runway into 1Q27
2025-05-23
07:20:30
Sol-Gel Technologies reports Q1 EPS ($3.20) vs. ($2.30) last year
2025-05-01 (ET)
2025-05-01
07:19:46
Sol-Gel Technologies announces 10-for-1 reverse share split
Sign Up For More Events
Sign Up For More Events
News
9.5
05-23Yahoo FinanceSol-Gel Reports First Quarter 2025 Results
9.5
05-23SeekingAlphaSol-Gel Technologies reports Q1 results
9.0
05-05TipRanksUpcoming Stock Splits This Week (May 5 to May 9) – Stay Invested
Sign Up For More News
People Also Watch
ZOOZ
Zooz Power Ltd
3.660
USD
+28.87%
WKHS
Workhorse Group Inc
1.940
USD
-6.73%
PMN
ProMIS Neurosciences Inc
0.987
USD
+8.94%
UBX
UNITY Biotechnology Inc
0.173
USD
-49.98%
JOB
GEE Group Inc
0.231
USD
+4.06%
DARE
Dare Bioscience Inc
2.570
USD
-2.28%
HUIZ
Huize Holding Ltd
2.646
USD
-0.15%
SWIN
Solowin Holdings Ltd
3.775
USD
+3.71%
NXPL
NextPlat Corp
0.760
USD
-5.59%
CMBM
Cambium Networks Corp
0.940
USD
-9.62%
FAQ
What is Sol Gel Technologies Ltd (SLGL) stock price today?
The current price of SLGL is 11 USD — it has decreased -0.99 % in the last trading day.
What is Sol Gel Technologies Ltd (SLGL)'s business?
What is the price predicton of SLGL Stock?
What is Sol Gel Technologies Ltd (SLGL)'s revenue for the last quarter?
What is Sol Gel Technologies Ltd (SLGL)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Sol Gel Technologies Ltd (SLGL)'s fundamentals?
How many employees does Sol Gel Technologies Ltd (SLGL). have?